-
A new antidepressant that combines selective serotonin reuptake inhibition with partial agonism of the 5-HT1A receptor has been approved by the FDA. Vilazodone is marketed by Trovis Pharmaceuticals as Viibryd(TM).
-
The ECG above was obtained in the office from an older woman with hypertension and atypical chest discomfort. Has there been anterior infarction, or is this a "pseudo-infarct" pattern?
-
A common presenting complaint for patients seeking emergency medical care is acute abdominal pain. Although difficult to diagnose in healthy patients, it is even more challenging in special populations. This article will focus on three distinct populations: patients with altered immunologic function, pregnant women, and post-procedural patients.
-
-
-
-
IRB professionals might not have gotten into the business of protecting human subjects because of their love for mathematics and statistics. But many now are finding that tracking data and analyzing numbers helps them do their job better.
-
When internal job mobility is stagnated, it can result in high staff turnover rates a problem no IRB wants to experience.
-
IRB offices routinely handle protocol submissions that are incomplete or flawed in other fundamental ways. These problems cause roadblocks that slow down the IRB approval process and frustrate investigators and IRB staff alike.
-
You are nearing the end of a busy shift in your emergency department (ED) when pre-hospital providers arrive with your next patient. They bring in a 69-year-old male with a chief complaint of headache and chest pain. Emergency medical services (EMS) activated him as a "code STEMI" in the field. He is hypertensive, diaphoretic, and complaining of a headache and chest pain on arrival.
